Abstract
Allogeneic haematopoietic cell transplantation (HCT) is a curative procedure for patients with haematological malignancies and immune deficiencies. A human leukocyte antigen (HLA) identical sibling is only available for 25–35% of patients in need. The improvement in haplo-identical transplantation has led to a marked increase in cell donation from relatives. Despite international recommendations, discrepancies in related-donors (RD) care exist between centres, particularly regarding medical suitability criteria, consenting procedures and donor follow-up. This European survey aimed to explore hematopoietic cell transplantation coordinators nurses’ (HCT-CNs) perceptions of RD care, in particular the association with the presence or not of an independent unit (IU). Ninety-three HCT-CNs from seventy-six EBMT centres responded, representing 19 countries (response rate: 27%). Our results did not show a significant association between IU and HCT-CNs perceptions of related-donors care. The practices for RD care vary among centres regarding presence or not of an IU (48%), person caring for RD (haematologist in 54%, HCT physician in 17%, HCT-CNs in 20%), person to whom the results of HLA typing are communicated, use of a booklet for RD, follow-up or not and periodicity of follow-up. Qualitative data highlight the related-donation ethical issues and the need for improvement in RD care. HCT-CNs’ main concerns were: the necessary confidentiality to insure the voluntary status of RD, the perceived conflict of interest felt by professionals when managing both patients and RD, plus the psychosocial aspects of related-donation. Even if there is a variety of a practice among centres, the presence of an IU is not significantly associated with an improvement in RD care.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2015;21:1863–1869.
Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, et al. Indications for the European Society for Blood and Marrow Transplantation (EBMT)Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe. 2019. Bone Marrow Transpl. 2019. https://doi.org/10.1038/s41409-019-0516-2.
Boo M, van Walraven SM, Chapman J, Lindberg B, Schmidt AH, Shaw BE. on behalf of the world marrow donor association. Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donors Association. Blood. 2011;117:21–25.
Kekre N, Antin JH. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood. 2014;124:334–343.
Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, et al. T-cell–replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31:1310–1316.
Martinez C, Gayoso J, Canals C, Finel H, Peggs K, Dominietto A, et al. Post-transplantation cyclophosphamide based haploidentical transplantation as alternative to matched sibling or unrelated donor transplantation for hodgkin lymphoma: a registry study of the lymphoma working party of the European Society for Blood and Marrow Transplantation. J Clin Oncol. 2017;35:3425–3432.
Raiola AM, Dominieto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transplant. 2014;20:1573–1579.
Kanate AS, Mussetti A, Kharfan-Dabaja MA. Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. Blood. 2016;127:938–947.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, et al. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant. 2015;50:476–482.
Passweg JR, Baldomero H, Badera P, Bonini C, Duarte RF, Dufour C, et al. for the European Society for Blood and Marrow Transplantation (EBMT). Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant. 2017;52:811–817.
Van Walraven SM, Nicolo-de-Faveri G, Axdorph-Nygell UA, Douglas KW, Jones DA, Lee SJ, on behalf of the World Marrow Donors Association Ethics and Clinical working groups. Family donor care management: principles and recommendations. Bone Marrow Transplant. 2010;45:1269–1273.
Foundation for the Accreditation of Cellular Therapy and the Joint Accreditation Committee – ISCT and EBMT. International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration, 7th ed. FACT-JACIE, 2017. http://www.ebmt.org/sites/default/files/2018-06/FACT-JACIE%207th%20Edition%20Standards.pdf.
O’Donnel PV, Petersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D, et al. Practice patterns for evaluation, consent and care of related donors and recipients at hematopoietic cell transplantation centers in the USA. Blood. 2010;115:5097–5101.
Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kambl RT, et al. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol Blood Marrow Transpl. 2017;22:520–527.
Coluccia P, Crovetti G, Del Fante C, Dallavalle FM, Laszlò D, Ferremi P, et al. Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres. Blood Transfus. 2012;10:440–447.
Anthias C, Peniket A, Kirkland K, Madrigal JA, Shaw BE. Variations in practice in UK transplant centers: results of a related donor care survey. Bone Marrow Transplant. 2016;51:1612–1614.
Clare S, Mank A, Stone R, Davies M, Potting C, Apperley JF, on behalf of the Research Sub-committee of the European Group for Blood and Marrow Transplantation Nurses Group. Management of related donor care: a European survey. Bone Marrow Transplant. 2010;45:97–101.
Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso, et al. Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant. 2013;48:220–225.
Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009;94:94–101.
Siddiq S, Phamphilon D, Brunskill S, Doree C, Hyde C, Stanworth S. Bone marrow harvest versus peripheral stem cell collection for haemotopoietic stem cell donation in healthy donors. Cochrane Database Syst Rev. 2009;21:CD006406.
Muzenberger N, Fortanier C, Macquart-Moulin G, Faucher C, Novakovitch G, Maraninchi D, et al. Psychosocial aspects of hematopoietic stem cell donation for allogeneic transplantation: how family donors cope with this experience. Psychooncology. 1999;8:55–63.
Christopher KA. The experience of donating bone marrow to a relative. Oncol Nurs Forum. 2000;27:693–700.
Williams S, Green R, Morrison A, Watson D, Buchanan S. The psychosocial aspects of donating blood stem cells: the sibling donor perspective. J Clin Apher. 2003;18:1–9.
Pillay B, Lee SJ, Katona L, De Bono S, Warren N, Fletcher J, et al. The psychosocial impact of hematopoietic SCT on sibling donors. Bone Marrow Transplant. 2012;47:1361–1365.
Polomeni A, Bompoint C, Gomez A, Brissot E, Ruggeri A, Mohty M. Current practices for screening, consent and care of related donors in France: haematopoietic stem cell transplantation coordinator nurses’ perceptions. Eur J Cancer Care. 2016;00:1–15.
Muramatsu H, Kimura S, Ichinohe T, Ashihara E, Ishikawa T, Maekawa T, et al. Consulting clinic for related family donors in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:1073–1075.
Kisch A, Dykes J, Lindmark A, Lenhoff S. A proposed plan for the management of adult sibling donors. Bone Marrow Transplant. 2008;42:357–358.
Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess R, editors. Anal. Qual. Data. London: Routledge; 1994. p. 173–194.
Ward DJ, Furber C, Tierney S, Swallow V. Using framework analysis in nursing research: a worked example. J Adv Nurs. 2013;69:2423–2431.
Smith J, Firth J. Qualitative data analysis: the framework approach. Nurse Res. 2011;18:52–62.
QSR International Pty Ltd. NVivo qualitative data analysis software Version 8. QSR International Pty Ltd. 2008. https://www.qsrinternational.com/nvivo/home.
Anthias C, vanWalraven SM, Sorensens de Faveri GN, Fechter M, Cornish J, et al. Related hematopoietic cell donor care: is there a role for unrelated donor registries? Bone Marrow Transplant. 2015;50:637–641.
Billen A, Madrigal JA, Shaw BR. A review of hematopoietic stem cell donation experience: is there room for improvement? Bonne Marrow Transplant. 2014;49:729–736.
El-Ghariani K, Dalle JH. Ethical issues in HSCT. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook, SpringerOpen; 2019. p. 245–249. https://doi.org/10.1007/978-3-030-02278-5.
Kisch A, Lenhoff S, Bengtsson M, Bolmsjö I. Potential adult sibling stem cell donors’ perceptions and opinions regarding an information and care model. Bone Marrow Transplant. 2013;48:1133–1137.
Garcia MC, Chapman JR, Shaw JP, Gottlieb DJ, Ralph A, Craig JC, et al. Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. Biol Blood Marrow Transpl. 2013;19:1046–1058.
Switzer GE, Dew MA, Magistro CA, Goycoolea JM, Twillman RK, Alter C, et al. The effects of bereavement on adult sibling bone marrow donors’ psychological well-being and reactions to donation. Bone Marrow Transplant. 1998;21:181–188.
Chang G, McGarigle C, Koby D, Antin JH. Symptoms of pain and depression in related marrow donors: changes after transplant. Psychosomatics. 2003;44:59–64.
Van Walraven SM, Ball LM, Koopman HM, Switzer GE, Ropes-de Jong CM, de Jong A, et al. Managing a dual role - experiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children. Psycho-Oncology. 2012;21:168–175.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Polomeni, A., Bompoint, C., Labopin, M. et al. Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group. Bone Marrow Transplant 55, 623–632 (2020). https://doi.org/10.1038/s41409-019-0686-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-019-0686-y